Other languages Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
68.41 ^USD	-0.20%		+1.74%	-4.48%

May. 16	Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM
May. 07	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	May. 07
Intra-Cellular Therapies' Q1 Net Loss Narrows, Net Total Revenue Rises	May. 07
Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07
Intra-Cellular Therapies, Inc. Reiterates Earnings Guidance for the Full Year 2024	May. 07
US Stocks Lacking Direction Prior to Powell Remarks, Investors Looking for Signs of Future Rate Cuts by Federal Reserve	Apr. 16
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	Apr. 16
Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President	Mar. 19
Intra-Cellular Therapies, Inc. Announces Executive Changes	Mar. 19
Intra-Cellular Therapies Insider Sold Shares Worth $1,458,650, According to a Recent SEC Filing	Feb. 29
Intra-Cellular Therapies Insider Sold Shares Worth $1,808,253, According to a Recent SEC Filing	Feb. 28
Intra-Cellular Therapies Q4 Loss Narrows, Revenue Increases	Feb. 22
Intra-Cellular Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22
Intra-Cellular Therapies, Inc. Provides Earnings Guidance for the Full Year 2024	Feb. 22
Intra-Cellular Therapies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22
Intra-Cellular Therapies Insider Sold Shares Worth $2,272,694, According to a Recent SEC Filing	Feb. 06
Intra-cellular Therapies Insider Sold Shares Worth $787,719, According to a Recent SEC Filing	Feb. 06
Intra-cellular Therapies Insider Sold Shares Worth $796,367, According to a Recent SEC Filing	Feb. 06
Intra-cellular Therapies Insider Sold Shares Worth $414,355, According to a Recent SEC Filing	Feb. 06
Intra-cellular Therapies Insider Sold Shares Worth $12,680,892, According to a Recent SEC Filing	Jan. 19
Intra-cellular Therapies Insider Sold Shares Worth $3,341,699, According to a Recent SEC Filing	Jan. 16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Other languages

Filters